Long-term partnership secures high-quality active pharmaceutical ingredient supply for Lasix(R) ONYU and future pipeline products BURLINGTON, Mass. and VICENZA, Italy, April 15, 2026 /PRNewswire/ -- ...
Autonomous continuous processing transforms API manufacturing with inline NMR, AI-driven control, and real-time optimization ...
Hovione’s multimillion-dollar investment in its East Windsor, NJ manufacturing site is coming to fruition, as detailed at ...
The global contract development and manufacturing organization announced March 23 it completed initial engineering studies for an expanded facility in Charles City, Iowa. Groundbreaking for the new ...
Wilmington PharmaTech (“Wilmington”), a leading U.S.-based research, development, and manufacturing organization (CRDMO) focused on complex custom small-molecule API production, today announced a $50 ...
With a substantial manufacturing base already locked down in China, CRDMO BioDuro is taking a short jaunt down to Taiwan for its latest drug ingredients production play. BioDuro, headquartered in ...
Biopharmaceutical company AbbVie plans to spend $380 million building two new manufacturing facilities in North Chicago — a rare example of a project that’s in line with initiatives by the ...
As Recipharm continues to refine its footprint, the CDMO is selling its development and small-scale active pharmaceutical ingredient (API) manufacturing facility in Yavne, Israel, to Scinai ...
QINGDAO, CHINA, January 19, 2026 /EINPresswire.com/ — As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened ...
Active pharmaceutical ingredients (APIs) form the backbone of modern medicine, driving the efficacy and safety of countless therapeutic products. According to a recent report by MarketsandMarkets, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results